Sydney, New South Wales Mar 20, 2024 (Issuewire.com) - Red acne marks are the residual pink or reddish marks left after an acne breakout. Red acne marks are also known as post-inflammatory erythema (PIE).
Red acne marks may look like brown acne marks and be treated like brown acne marks, but for decades, beauty experts have been doing it all wrong.
Médicii Laboratories explains red acne marks occur when there is significant inflammation and a rush of blood flow to the skin's surface. This sudden increase in blood flow causes damage to blood capillaries and the formation of tiny new blood vessels, resulting in the pink or reddish hues you can see on the skin's surface. For this reason, melanin-reducing ingredients such as Retinol and chemical exfoliants such as beta-hydroxy acids (BHA) and alpha-hydroxy acids (AHA) will not remove red acne marks.
Retinamide Forté Red Scar Therapy Gel is an Australian-made natural scar gel scientifically formulated to target red acne marks by reducing inflammation without corticosteroids. Unlike other scar products that have silica as their only active ingredient, Retinamide Forté Red Scar Therapy Gel also contains Inflammaid and Manuka Honey. These two ingredients help to reduce inflammation and stop post-inflammatory erythema in its tracks, preventing red acne marks from becoming brown marks.
According to Médicii Laboratories, "Hair loss is caused by many factors, one of which is scalp inflammation. Elle Derm Australia has proprietary ingredients that have proven to show phenomenal results when it comes to reducing inflammation within a short period. We are excited to see how this can be used for helping patients with hair loss."
Developed by an Australian pharmacist, Retinamide Forté Red Scar Therapy Gel is available at Médicii Laboratories and skin cancer clinics around Australia. This unique red scar gel is also used to prevent scars from post-operative procedures and laser therapy.
Media Contact
Medicii Laboratories
Source :Medicii Laboratories
This article was originally published by IssueWire. Read the original article here.
